Serina Therapeutics, Inc. (SER) Dividend History

Serina Therapeutics, Inc. (SER) is a biopharmaceutical company focused on developing targeted therapies for rare and severe medical conditions, including hospital-based indications such as opioid-resistant pain. The company aims to leverage its proprietary peptide platform to develop innovative drugs that address unmet medical needs.